Diagnosis of CTDs typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests may reveal autoantibodies, such as antinuclear antibodies (ANAs), which are often present in autoimmune CTDs. Imaging studies, such as X-rays or MRIs, can help assess the extent of tissue involvement and damage.
